|
Volumn 20, Issue 11, 2014, Pages 1224-1225
|
FDA's post-approval studies continue to suffer delays and setbacks
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MAFENIDE;
CLINICAL TRIAL (TOPIC);
DRUG APPROVAL;
DRUG INDUSTRY;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE POLICY;
HUMAN;
LEGISLATION AND JURISPRUDENCE;
UNITED STATES;
CLINICAL TRIALS AS TOPIC;
DRUG APPROVAL;
DRUG INDUSTRY;
HEALTH POLICY;
HUMANS;
MAFENIDE;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84922393631
PISSN: None
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm1114-1224 Document Type: Note |
Times cited : (9)
|
References (0)
|